|
|
|
Volumn 3, Issue SUPPL. 1, 1997, Pages
|
|
Interleukin-2 in the treatment of hematologic malignancies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD56 ANTIGEN;
INTERLEUKIN 2;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
CANCER IMMUNOLOGY;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
EDITORIAL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOSTIMULATION;
LYMPHOCYTE ACTIVATION;
NONHODGKIN LYMPHOMA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
HEMATOLOGIC NEOPLASMS;
HUMANS;
IMMUNOTHERAPY;
INTERLEUKIN-2;
|
|
EID: 0031424670
PISSN: 10814442
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (4)
|
|
References (10)
|
